Lantheus Holdings, Inc. → PROGENICS PHARMACEUTICALS INC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on PROGENICS PHARMACEUTICALS INC

Filed	Form	Filer	Stake	Shares
2020-04-15	SC	Altiva Management Inc.	—	—	view →
2020-04-09	SC	Altiva Management Inc.	—	—	view →
2019-11-12	SC	Altiva Management Inc.	—	—	view →
2019-09-19	SC	Altiva Management Inc.	—	—	view →
2019-08-26	SC	Altiva Management Inc.	—	—	view →
2019-05-01	SC	Altiva Management Inc.	—	—	view →

Other Filings by Lantheus Holdings, Inc.

Filed	Form	Issuer	Stake	Shares
2026-09-04	SCHEDULE 13D	Radiopharm Theranostics Limited	20.90%	792,958,513	view →
2026-09-04	SCHEDULE 13D/A	Perspective Therapeutics, Inc.	10.00%	11,440,513	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →